{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:51:17Z","timestamp":1784231477135,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ijantimicag.2019.11.009","type":"journal-article","created":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T11:16:00Z","timestamp":1574507760000},"page":"105852","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Activity of ceftazidime-avibactam alone and in combination with polymyxin B against carbapenem-resistant Klebsiella pneumoniae in a tandem in vitro time-kill\/in vivo Galleria\u00a0mellonella survival model analysis"],"prefix":"10.1016","volume":"55","author":[{"given":"Jovan","family":"Borjan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin A.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan K.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Wenzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2019.11.009_bib0001","unstructured":"Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2013. Available fromhttp:\/\/www.cdc.gov\/drugresistance\/threat-report-2013\/pdf\/ar-threats-2013-508.pdf. Accessed January 26 2015."},{"key":"10.1016\/j.ijantimicag.2019.11.009_bib0002","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/jac\/dkq108","article-title":"Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection","volume":"65","author":"Hirsch","year":"2010","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.ijantimicag.2019.11.009_bib0003","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00883-17","article-title":"Ceftazidime-avibactam is superior to other treatment regimens against carbapenem-resistant Klebsiella pneumoniae bacteremia","volume":"61","author":"Shields","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.11.009_bib0004","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/cid\/cix783","article-title":"Colistin vs. ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant Enterobacteriaceae","volume":"66","author":"van Duin","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.11.009_bib0005","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/QCO.0000000000000495","article-title":"Combination versus monotherapy for the treatment of infections due to carbapenem-resistant Enterobacteriaceae","volume":"31","author":"Carrara","year":"2018","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.11.009_bib0006","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijantimicag.2018.10.010","article-title":"Combination therapy with polymyxin B for carbapenemase-producing Klebsiella pneumoniae bloodstream infection","volume":"53","author":"Medeiros","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2019.11.009_bib0007","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/cid\/ciw636","article-title":"Clinical outcomes, drug toxicity, and emergence of ceftazidime-avibactam resistance among patients treated for carbapenem-resistant Enterobacteriaceae infections","volume":"63","author":"Press","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.11.009_bib0008","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/QCO.0000000000000493","article-title":"Optimizing therapy in carbapenem-resistant Enterobacteriaceae infections","volume":"31","author":"Tumbarello","year":"2018","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.11.009_bib0009","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/jac\/dkx419","article-title":"In vitro and in vivo activity of single and dual antimicrobial agents against KPC-producing Klebsiella pneumoniae","volume":"73","author":"Nath","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.ijantimicag.2019.11.009_bib0010","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01018-18","article-title":"Colistin does not potentiate ceftazidime-avibactam killing of carbapenem-resistant Enterobacteriaceae in vitro or suppress emergence of ceftazidime-avibactam resistance","volume":"62","author":"Shields","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.11.009_bib0011","article-title":"Emergence of ceftazidime-avibactam resistance due to plasmid-borne blaKPC-3 mutations during treatment of carbapenem-resistant Klebsiella pneumoniae infections","volume":"61","author":"Shields","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.11.009_bib0012","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofx101","article-title":"Emergence of ceftazidime-avibactam resistance and restoration of carbapenem susceptibility in Klebsiella pneumoniae carbapenemase-producing K pneumoniae: a case report and review of literature","volume":"4","author":"Shields","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.11.009_bib0013","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1093\/jac\/dkx179","article-title":"Emergence of ceftazidime\/avibactam non-susceptibility in an MDR Klebsiella pneumoniae isolate","volume":"72","author":"Both","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.11.009_bib0014","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.femsim.2004.11.003","article-title":"Invertebrates as animal models for Staphylococcus aureus pathogenesis: a window into host-pathogen interaction","volume":"43","author":"Garcia-Lara","year":"2005","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.11.009_bib0015","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1128\/JB.182.13.3843-3845.2000","article-title":"Positive correlation between virulence of Pseudomonas aeruginosa mutants in mice and insects","volume":"182","author":"Jander","year":"2000","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2019.11.009_bib0016","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/mpat.2002.0494","article-title":"Silkworm larvae as an animal model of bacterial infection pathogenic to humans","volume":"32","author":"Kaito","year":"2002","journal-title":"Microb Pathog"},{"key":"10.1016\/j.ijantimicag.2019.11.009_bib0017","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1128\/AAC.01533-08","article-title":"Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics","volume":"53","author":"Peleg","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.11.009_bib0018","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s10096-008-0680-6","article-title":"Hospital infections, animal models and alternatives","volume":"28","author":"Seabra","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.11.009_bib0019","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1093\/jac\/dkz010","article-title":"In vitro activity of oritavancin alone or in combination against vancomycin-susceptible and -resistant enterococci","volume":"74","author":"Wu","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.11.009_bib0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijantimicag.2019.04.010","article-title":"Efficacy of oritavancin alone and in combination against vancomycin-susceptible and resistant enterococci in an in vivo Galleria mellonella survival model","volume":"54","author":"Meyer","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2019.11.009_bib0021","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01415-17","article-title":"FDA-CDC antimicrobial resistance isolate bank: a publicly available resource to support research, development, and regulatory requirements","volume":"56","author":"Lutgring","year":"2018","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.11.009_bib0022","series-title":"Performance Standards for Antimicrobial Susceptibility Testing: Approved Twenty-Eighth Edition: Document M100-S28","year":"2018"},{"key":"10.1016\/j.ijantimicag.2019.11.009_bib0023","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1111\/ajt.12424","article-title":"Epidemiology and molecular characterization of bacteremia due to carbapenem-resistant Klebsiella pneumoniae in transplant recipients","volume":"13","author":"Clancy","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ijantimicag.2019.11.009_bib0024","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1128\/JCM.01314-09","article-title":"Use of boronic acid disk tests to detect extended-spectrum beta-lactamases in clinical isolates of KPC carbapenemase-possessing Enterobacteriaceae","volume":"47","author":"Tsakris","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.11.009_bib0025","series-title":"Methods for Determining Bactericidal Activity of Antimicrobial Agents: Approved Guideline: Document M26-A","year":"1999"},{"key":"10.1016\/j.ijantimicag.2019.11.009_bib0026","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.1128\/AAC.00548-15","article-title":"Effects of Klebsiella pneumoniae carbapenemase subtypes, extended-spectrum beta-lactamases, and porin mutations on the in vitro activity of ceftazidime-avibactam against carbapenem-resistant K","volume":"59","author":"Shields","year":"2015","journal-title":"pneumoniae. Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.11.009_bib0027","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1128\/AAC.04218-14","article-title":"In vitro antibacterial activity of the ceftazidime-avibactam combination against Enterobacteriaceae, including strains with well-characterized \u03b2-lactamases","volume":"59","author":"Levasseur","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.11.009_bib0028","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00537-17","article-title":"Resistance to ceftazidime-avibactam in Klebsiella pneumoniae Due to porin mutations and the increased expression of KPC-3","volume":"61","author":"Humphries","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.11.009_bib0029","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00989-17","article-title":"Resistance to ceftazidime-avibactam is due to transposition of KPC in a porin-deficient strain of Klebsiella pneumoniae with increased efflux activity","volume":"61","author":"Nelson","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.11.009_bib0030","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1128\/AAC.01069-13","article-title":"Mutations of the ompK36 porin gene and promoter impact responses of sequence type 258, KPC-2-producing Klebsiella pneumoniae strains to doripenem and doripenem-colistin","volume":"57","author":"Clancy","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.11.009_bib0031","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/cid\/ciw741","article-title":"Comparing the outcomes of patients with carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant Enterobacteriaceae bacteremia","volume":"64","author":"Tamma","year":"2017","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919303231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919303231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:33:56Z","timestamp":1760376836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857919303231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0924857919303231"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.11.009","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activity of ceftazidime-avibactam alone and in combination with polymyxin B against carbapenem-resistant Klebsiella pneumoniae in a tandem in vitro time-kill\/in vivo Galleria\u00a0mellonella survival model analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105852"}}